Generic Oncology Drugs Market Revenue at around US$ 23 Bn in 2020, which is predicted to rise to US$ 41.5 Bn by the end of 2031.The generic oncology drugs market is predicted to rise at a CAGR of around 6% over the decade. Rising incidence of cancer cases, increasing geriatric population, rising healthcare expenditure, and government initiatives to increase cancer treatment scope are some of...